Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2024-11-04 00:00:00 ET · period of report 2024-10-31 · accession 0001140361-24-045101 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-04 | 2024-10-31 | RCKT | White Mark Andrew | See Remarks | S - Sale | $16.63 | -3,080 | 69.1K | -4% | -$51.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-31 | S | D | 3,080 | $16.63 | 69,140 | D | — | — | (F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. |